RESISTENCIA A TRATAMIENTO DE LEUCEMIA MIELOIDE CRONICA

MONICA ROCIO MOSQUERA RODRIGUEZ
ROBERTO JOSE RODRIGUEZ FLOREZ

ESTRATEGIA DE BUSQUEDA:

((Leukemia, myeloid, chronic phase[All Fields]) AND ((("Leukemia, Myeloid, Chronic-Phase"[MeSH] OR ("Leukemia, Myeloid, Chronic-Phase/drug therapy"[MeSH] OR "Leukemia, Myeloid, Chronic-Phase/prevention and control"[MeSH] OR "Leukemia, Myeloid, Chronic-Phase/surgery"[MeSH] OR "Leukemia, Myeloid, Chronic-Phase/therapy"[MeSH])) AND (English[lang] OR Spanish[lang]) AND (Humans[Mesh]) AND "2002/05/04 18.58" : "2007/05/04 18.58"[PDat]))) AND ((resistance to the treatment chronic myeloid leukemia))
Limits: English, Spanish, published in the last 5 years, Humans

Entrez pubmed Results

Items 1 - 9 of 9

1:	Timeus F, Crescenzio N, Ricotti E, Doria A, Bertin D, Saglio G, Tovo PA.	Related Articles, Compound via MeSH, Substance via MeSH, LinkOut
	The effects of saquinavir on imatinib-resistant chronic myelogenous leukemia cell lines. Haematologica. 2006 May;91(5):711-2. PMID: 16670078 [PubMed - indexed for MEDLINE]

2:	Zheng C, Li L, Haak M, Brors B, Frank O, Giehl M, Fabarius A, Schatz M, Weisser A, Lorentz C, Gretz N, Hehlmann R, Hochhaus A, Seifarth W.	Related Articles, Compound via MeSH, Substance via MeSH, LinkOut
	Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis. Leukemia. 2006 Jun;20(6):1028-34. PMID: 16617318 [PubMed - indexed for MEDLINE]

3:	von dem Borne PA, van Luxemburg-Heijs SA, Heemskerk MH, Jedema I, Mulder A, Willemze R, Falkenburg JH.	Related Articles, LinkOut
	Molecular persistence of chronic myeloid leukemia caused by donor T cells specific for lineage-restricted maturation antigens not recognizing immature progenitor-cells. Leukemia. 2006 Jun;20(6):1040-6. PMID: 16525495 [PubMed - indexed for MEDLINE]

4:	Prebet T, Tigaud I, Hayette S, Clapisson G, Philip I, Michallet M, Nicolini FE.	Related Articles, Compound via MeSH, Substance via MeSH, LinkOut
	Mobilization of autologous hematopoietic progenitors and subsequent transplantation is a safe and feasible procedure in chronic phase chronic myelogenous leukemia patients with cytogenetic resistance to imatinib. Haematologica. 2005 Nov;90 Suppl:ECR36. No abstract available. PMID: 16266927 [PubMed - indexed for MEDLINE]

5:	Soverini S, Martinelli G, Rosti G, Bassi S, Amabile M, Poerio A, Giannini B, Trabacchi E, Castagnetti F, Testoni N, Luatti S, de Vivo A, Cilloni D, Izzo B, Fava M, Abruzzese E, Alberti D, Pane F, Saglio G, Baccarani M.	Related Articles, Compound via MeSH, Substance via MeSH, Cited in PMC, LinkOut
	ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia. J Clin Oncol. 2005 Jun 20;23(18):4100-9. Epub 2005 May 2. PMID: 15867198 [PubMed - indexed for MEDLINE]

6:	Agirre X, Fontalba A, Andreu EJ, Odero MD, Larrayoz MJ, Montiel C, Calasanz MJ, Fernandez-Luna JL, Prosper F.	Related Articles, Compound via MeSH, Substance via MeSH, LinkOut
	Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response. Haematologica. 2003 Dec;88(12):1425-6. No abstract available. PMID: 14687999 [PubMed - indexed for MEDLINE]

7:	Cervantes F, Hernandez-Boluda JC, Steegmann JL, Conde E, Alvarez-Larran A, Lopez-Jimenez J, Osorio S, Villalon L, Camos M, Garcia-Conde J, Odriozola J.	Related Articles, Compound via MeSH, Substance via MeSH, LinkOut
	Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients. Haematologica. 2003 Oct;88(10):1117-22. PMID: 14555307 [PubMed - indexed for MEDLINE]

8:	Gardembas M, Rousselot P, Tulliez M, Vigier M, Buzyn A, Rigal-Huguet F, Legros L, Michallet M, Berthou C, Cheron N, Maloisel F, Mahon FX, Facon T, Berthaud P, Guilhot J, Guilhot F; CML French Group.	Related Articles, Compound via MeSH, Substance via MeSH, LinkOut
	Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase. Blood. 2003 Dec 15;102(13):4298-305. Epub 2003 Aug 21. PMID: 12933584 [PubMed - indexed for MEDLINE]

9:	Olavarria E, Reiffers J, Boque C, Sureda A, Meloni G, Michallet M, Clark RE, Blaise D, Carella AM, Cahn JY, Jouet JP, Rizzoli V, Van Biezen A, Gratwohl A, Goldman JM, Niederwieser D, Apperley JF.	Related Articles, Substance via MeSH, LinkOut
	The post-transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase. Br J Haematol. 2002 Sep;118(3):762-70. PMID: 12181043 [PubMed - indexed for MEDLINE]

---